Genome-wide association studies (GWAS) identified variants at 19p13.1 and ZNF365 (10q21.2) as risk factors for breast cancer among BRCA1 and BRCA2 mutation carriers, respectively. We explored associations with ovarian cancer and with breast cancer by tumor histopathology for these variants in mutation carriers from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)
Introduction: Several common alleles have been shown to be associated with breast and/or ovarian can...
BRCA1-associated breast and ovarian cancer risks can be modified by common genetic variants. To iden...
BRCA1-associated breast and ovarian cancer risks can be modified by common genetic variants. To iden...
Genome-wide association studies (GWAS) identified variants at 19p13.1 and ZNF365 (10q21.2) as risk f...
BACKGROUND: Genome-wide association studies (GWAS) identified variants at 19p13.1 and ZNF365 (10q21....
Background: Genome-wide association studies (GWAS) identified variants at 19p13.1 and ZNF365 (10q21....
BRCA1-associated breast and ovarian cancer risks can be modified by common genetic variants. To iden...
Introduction: Several common alleles have been shown to be associated with breast and/or ovarian can...
BRCA1-associated breast and ovarian cancer risks can be modified by common genetic variants. To iden...
BRCA1-associated breast and ovarian cancer risks can be modified by common genetic variants. To iden...
Genome-wide association studies (GWAS) identified variants at 19p13.1 and ZNF365 (10q21.2) as risk f...
BACKGROUND: Genome-wide association studies (GWAS) identified variants at 19p13.1 and ZNF365 (10q21....
Background: Genome-wide association studies (GWAS) identified variants at 19p13.1 and ZNF365 (10q21....
BRCA1-associated breast and ovarian cancer risks can be modified by common genetic variants. To iden...
Introduction: Several common alleles have been shown to be associated with breast and/or ovarian can...
BRCA1-associated breast and ovarian cancer risks can be modified by common genetic variants. To iden...
BRCA1-associated breast and ovarian cancer risks can be modified by common genetic variants. To iden...